This course provides an in-depth exploration of advancements in epilepsy care, focusing on the intersection of genetics, precision therapies, and emerging technologies. Participants will gain a comprehensive understanding of the role of single-gene mutations and polygenic risk scores in shaping treatment strategies. The course also examines the application of precision therapies in personalized care and the transformative potential of AI, machine learning, and big data in seizure detection and management. Additionally, future innovations in epilepsy surgery and wearable technology are discussed, highlighting their contributions to improving precision and treatment outcomes.
This program has received an unrestricted educational grant or in-kind support from Paladin Pharma Inc.